Literature DB >> 25986140

Statins and Diabetes: The Plot Thickens.

Giacomo Gastaldi1, Jacques Philippe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25986140      PMCID： PMC4617931          DOI： 10.1007/s11606-015-3399-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  8 in total

1.  Effect of fitness on incident diabetes from statin use in primary prevention.

Authors:  Nina B Radford; Laura F DeFina; Carolyn E Barlow; Alice Kerr; Ripa Chakravorty; Amit Khera; Benjamin D Levine
Journal:  Atherosclerosis       Date:  2014-12-23       Impact factor: 5.162

2.  Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.

Authors:  Henna Cederberg; Alena Stančáková; Nagendra Yaluri; Shalem Modi; Johanna Kuusisto; Markku Laakso
Journal:  Diabetologia       Date:  2015-03-10       Impact factor: 10.122

3.  Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Authors:  David Preiss; Sreenivasa Rao Kondapally Seshasai; Paul Welsh; Sabina A Murphy; Jennifer E Ho; David D Waters; David A DeMicco; Philip Barter; Christopher P Cannon; Marc S Sabatine; Eugene Braunwald; John J P Kastelein; James A de Lemos; Michael A Blazing; Terje R Pedersen; Matti J Tikkanen; Naveed Sattar; Kausik K Ray
Journal:  JAMA       Date:  2011-06-22       Impact factor: 56.272

4.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

5.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Authors:  Daniel I Swerdlow; David Preiss; Karoline B Kuchenbaecker; Michael V Holmes; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Stefan Stender; Paul C D Johnson; Robert A Scott; Maarten Leusink; Niek Verweij; Stephen J Sharp; Yiran Guo; Claudia Giambartolomei; Christina Chung; Anne Peasey; Antoinette Amuzu; KaWah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; Yun R Li; Gordon Lowe; John Gallacher; Marlene C W Stewart; Ioanna Tzoulaki; Sarah G Buxbaum; Daphne L van der A; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Urszula Stepaniak; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Fabrizio Veglia; Ian Ford; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Pim A de Jong; Ale Algra; Wilko Spiering; Anke H Maitland-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Charles B Eaton; Jennifer G Robinson; David Duggan; John Kjekshus; John R Downs; Antonio M Gotto; Anthony C Keech; Roberto Marchioli; Gianni Tognoni; Peter S Sever; Neil R Poulter; David D Waters; Terje R Pedersen; Pierre Amarenco; Haruo Nakamura; John J V McMurray; James D Lewsey; Daniel I Chasman; Paul M Ridker; Aldo P Maggioni; Luigi Tavazzi; Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; JoAnn E Manson; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Pamela J Schreiner; Myriam Fornage; David S Siscovick; Mary Cushman; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Susan Redline; Sanjay R Patel; John C Whittaker; Anders Hamsten; Joseph A Delaney; Caroline Dale; Tom R Gaunt; Andrew Wong; Diana Kuh; Rebecca Hardy; Sekar Kathiresan; Berta A Castillo; Pim van der Harst; Eric J Brunner; Anne Tybjaerg-Hansen; Michael G Marmot; Ronald M Krauss; Michael Tsai; Josef Coresh; Ronald C Hoogeveen; Bruce M Psaty; Leslie A Lange; Hakon Hakonarson; Frank Dudbridge; Steve E Humphries; Philippa J Talmud; Mika Kivimäki; Nicholas J Timpson; Claudia Langenberg; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Alex P Reiner; Brendan J Keating; Aroon D Hingorani; Naveed Sattar
Journal:  Lancet       Date:  2014-09-24       Impact factor: 79.321

6.  Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.

Authors:  Ishak Mansi; Christopher R Frei; Chen-Pin Wang; Eric M Mortensen
Journal:  J Gen Intern Med       Date:  2015-04-28       Impact factor: 5.128

Review 7.  Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis.

Authors:  Sebhat Erqou; C Christine Lee; Amanda I Adler
Journal:  Diabetologia       Date:  2014-09-23       Impact factor: 10.122

8.  Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.

Authors:  Colin R Dormuth; Kristian B Filion; J Michael Paterson; Matthew T James; Gary F Teare; Colette B Raymond; Elham Rahme; Hala Tamim; Lorraine Lipscombe
Journal:  BMJ       Date:  2014-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.